🟢 Femasys is trading 6.86% up today after Minnesota Women's Care added FemVue, FemaSeed Complete

Femasys is trading 6.86% higher at $2.74 after Minnesota Women’s Care announced adoption of FemVue and FemaSeed Complete across all four of its locations.

• The September 15 announcement expands Femasys’ OB/GYN commercial footprint and provides fertility diagnostics plus in-office first-line treatment.
• Shares declined 4.12% during the September 15 regular session before the adoption announcement supported renewed buying interest.